mouse monoclonal anti gbb (Developmental Studies Hybridoma Bank)
Developmental Studies Hybridoma Bank is a verified supplier 
Developmental Studies Hybridoma Bank manufactures this product 
96
Structured Review
Developmental Studies Hybridoma Bank
mouse monoclonal anti gbb
Mouse Monoclonal Anti Gbb, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 96/100, based on 202 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+monoclonal+anti+gbb/anti-LAMP-1/sidisky_jessica_m__2023__maintaining_synaptic_integrity_in_aging_and_neuromuscular_diseases-164-12-16
Average 96 stars, based on 202 article reviews
Mouse Monoclonal Anti Gbb, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 96/100, based on 202 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+monoclonal+anti+gbb/anti-LAMP-1/sidisky_jessica_m__2023__maintaining_synaptic_integrity_in_aging_and_neuromuscular_diseases-164-12-16
Average 96 stars, based on 202 article reviews
mouse monoclonal anti gbb - by Bioz Stars,
2026-10
96/100 stars
Images
Related Articles
Transfection:Article Title: Maintaining Synaptic Integrity in Aging and Neuromuscular Diseases Article Snippet: The following primary antibodies were treated for 48 hrs at 4° C, Construct:Article Title: Maintaining Synaptic Integrity in Aging and Neuromuscular Diseases Article Snippet: The following primary antibodies were treated for 48 hrs at 4° C, Plasmid Preparation:Article Title: Maintaining Synaptic Integrity in Aging and Neuromuscular Diseases Article Snippet: The following primary antibodies were treated for 48 hrs at 4° C, Recombinant:Article Title: Maintaining Synaptic Integrity in Aging and Neuromuscular Diseases Article Snippet: The following primary antibodies were treated for 48 hrs at 4° C, Sequencing:Article Title: Maintaining Synaptic Integrity in Aging and Neuromuscular Diseases Article Snippet: The following primary antibodies were treated for 48 hrs at 4° C, Isolation:Article Title: Maintaining Synaptic Integrity in Aging and Neuromuscular Diseases Article Snippet: The following primary antibodies were treated for 48 hrs at 4° C, In Situ:Article Title: Maintaining Synaptic Integrity in Aging and Neuromuscular Diseases Article Snippet: The following primary antibodies were treated for 48 hrs at 4° C, Cloning:Article Title: Maintaining Synaptic Integrity in Aging and Neuromuscular Diseases Article Snippet: The following primary antibodies were treated for 48 hrs at 4° C, cDNA Synthesis:Article Title: Maintaining Synaptic Integrity in Aging and Neuromuscular Diseases Article Snippet: The following primary antibodies were treated for 48 hrs at 4° C, SYBR Green Assay:Article Title: Maintaining Synaptic Integrity in Aging and Neuromuscular Diseases Article Snippet: The following primary antibodies were treated for 48 hrs at 4° C, Reverse Transcription:Article Title: Maintaining Synaptic Integrity in Aging and Neuromuscular Diseases Article Snippet: The following primary antibodies were treated for 48 hrs at 4° C, Software:Article Title: Maintaining Synaptic Integrity in Aging and Neuromuscular Diseases Article Snippet: The following primary antibodies were treated for 48 hrs at 4° C, Microscopy:Article Title: Maintaining Synaptic Integrity in Aging and Neuromuscular Diseases Article Snippet: The following primary antibodies were treated for 48 hrs at 4° C, |
